These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12102679

  • 1. Visual field constriction in 91 Finnish children treated with vigabatrin.
    Vanhatalo S, Nousiainen I, Eriksson K, Rantala H, Vainionpää L, Mustonen K, Aärimaa T, Alen R, Aine MR, Byring R, Hirvasniemi A, Nuutila A, Walden T, Ritanen-Mohammed UM, Karttunen-Lewandowski P, Pohjola LM, Kaksonen S, Jurvelin P, Granström ML.
    Epilepsia; 2002 Jul; 43(7):748-56. PubMed ID: 12102679
    [Abstract] [Full Text] [Related]

  • 2. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
    Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B.
    J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
    [Abstract] [Full Text] [Related]

  • 3. Visual field loss associated with vigabatrin: quantification and relation to dosage.
    Hardus P, Verduin WM, Engelsman M, Edelbroek PM, Segers JP, Berendschot TT, Stilma JS.
    Epilepsia; 2001 Feb; 42(2):262-7. PubMed ID: 11240600
    [Abstract] [Full Text] [Related]

  • 4. Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making.
    Paul SR, Krauss GL, Miller NR, Medura MT, Miller TA, Johnson MA.
    Epilepsia; 2001 Apr; 42(4):525-30. PubMed ID: 11440348
    [Abstract] [Full Text] [Related]

  • 5. Vigabatrin visual toxicity: evolution and dose dependence.
    Malmgren K, Ben-Menachem E, Frisén L.
    Epilepsia; 2001 May; 42(5):609-15. PubMed ID: 11380567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E, Jonsson H, Lappi M.
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [Abstract] [Full Text] [Related]

  • 8. Vigabatrin-associated visual field defects in children.
    Russell-Eggitt IM, Mackey DA, Taylor DS, Timms C, Walker JW.
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vigabatrin and epilepsy: lessons learned.
    Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB, Schiefer U, Perucca E.
    Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
    [Abstract] [Full Text] [Related]

  • 11. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
    Kinirons P, Cavalleri GL, O'Rourke D, Doherty CP, Reid I, Logan P, Liggan B, Delanty N.
    Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754
    [Abstract] [Full Text] [Related]

  • 12. Binasal visual field defects are not specific to vigabatrin.
    Gonzalez P, Sills GJ, Parks S, Kelly K, Stephen LJ, Keating D, Dutton GN, Brodie MJ.
    Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
    [Abstract] [Full Text] [Related]

  • 13. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study.
    Schmitz B, Schmidt T, Jokiel B, Pfeiffer S, Tiel-Wilck K, Rüther K.
    J Neurol; 2002 Apr; 249(4):469-75. PubMed ID: 11967655
    [Abstract] [Full Text] [Related]

  • 14. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
    Werth R, Schädler G.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy.
    Conway M, Cubbidge RP, Hosking SL.
    Epilepsia; 2008 Jan; 49(1):108-16. PubMed ID: 18184224
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD, Li M, Tsao J, Zhou R, Wu YW, Sankar R, Wu JY, Hussain SA.
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [Abstract] [Full Text] [Related]

  • 20. Visual impairment in children with epilepsy treated with vigabatrin.
    Gross-Tsur V, Banin E, Shahar E, Shalev RS, Lahat E.
    Ann Neurol; 2000 Jul; 48(1):60-4. PubMed ID: 10894216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.